Publicaciones (70) Publicaciones de SONIA GATIUS CALDERO

2024

  1. Cathecolaminergic storm with stress-induced cardiomyopathy secondary to pheochromocytoma

    Medicina Clinica, Vol. 162, Núm. 9, pp. e25

  2. FABP5 in keratinocyte carcinomas: expression, secretion, and its impact on tumor aggressiveness

    Archives of Dermatological Research

  3. Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review

    Cancers, Vol. 16, Núm. 1

  4. Molecular features for timely cancer diagnosis and treatment – tumors of the ovary, fallopian tube and endometrium

    Virchows Archiv, Vol. 484, Núm. 2, pp. 339-351

2023

  1. Biomarkers Found in the Tumor Interstitial Fluid may Help Explain the Differential Behavior Among Keratinocyte Carcinomas

    Molecular & cellular proteomics : MCP, Vol. 22, Núm. 6, pp. 100547

  2. In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers

    Advanced Science, Vol. 10, Núm. 32

  3. Molecular Pathology of Endometrial Tumors

    Molecular Surgical Pathology: Second Edition (Springer International Publishing), pp. 297-321

  4. Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness

    Molecular Oncology, Vol. 17, Núm. 1, pp. 98-118

  5. Performance of endobronchial ultrasound transbronchial needle aspiration as the first nodal staging procedure for the determination of programmed death ligand-1 expression in non-small cell lung cancer patients

    Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 13, pp. 12459-12468

  6. Validation of Modaplex POLE mutation assay in endometrial carcinoma

    Virchows Archiv, Vol. 483, Núm. 6, pp. 787-794

2022

  1. ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma

    Molecular Oncology, Vol. 16, Núm. 11, pp. 2235-2259

  2. Abdominal tumors in patients with neurofibromatosis type I: Genotype-phenotype relationships

    European Journal of Medical Genetics, Vol. 65, Núm. 11

  3. CRABP2 – A novel biomarker for high-risk endometrial cancer

    Gynecologic Oncology, Vol. 167, Núm. 2, pp. 314-322

  4. Comparison of the Idylla™ MSI assay with the Promega™ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study

    Virchows Archiv, Vol. 480, Núm. 5, pp. 1031-1039

  5. Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression

    Oncogene, Vol. 41, Núm. 13, pp. 1835-1850

  6. Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer

    Cancers, Vol. 14, Núm. 12

2021

  1. Brafv600e mutant allele frequency (Maf) influences melanoma clinicopathologic characteristics

    Cancers, Vol. 13, Núm. 20

  2. Diagnosis and management of an endometrial cancer patient with Cowden syndrome

    Gynecologic Oncology, Vol. 163, Núm. 1, pp. 14-21

  3. Differential Immunoexpression of BRAF/V600E, Senescence Markers, PTEN, and T-type Calcium Channels in Acquired Naevi According to their Histopathological and Dermoscopic Classification

    Acta Dermato-Venereologica, Vol. 101, Núm. 11

2020

  1. Descriptive study of naevus involution in a series of 74 patients with atypical naevus syndrome under SIAscopy digital follow-up

    Journal of the European Academy of Dermatology and Venereology, Vol. 34, Núm. 6, pp. 1210-1217